Consumption of a controlled low-fat diet containing olestra for 9 months improves health risk factors in conjunction with weight loss in obese men: The Olé Study

International Journal of Obesity

Volumn 27, Issue 10, 2003, Pages 1242-1249

  Lovejoy, J C ^a   Bray, G A ^a   Lefevre, M ^a   Smith, S R ^a   Most, M M ^a   Denkins, Y M ^a   Volaufova, J ^a   Rood, J C ^a   Eldridge, A L ^b,c   Peters, J C ^b  

^a PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

^b PROCTER AND GAMBLE COMPANY   (United States)

^c GENERAL MILLS INC   (United States)

Author keywords

Dietary fat; Heart disease; Lipoproteins; Type II diabetes

Indexed keywords

APOLIPOPROTEIN A; APOLIPOPROTEIN A1; APOLIPOPROTEIN B; BLOOD CLOTTING FACTOR 7; CHOLESTEROL; FAT; GLUCOSE; HEMOSTATIC AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; INSULIN; LEPTIN; LIPID; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL; SUCROSE POLYESTER; TRIACYLGLYCEROL;

ADULT; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE MEASUREMENT; BODY COMPOSITION; BODY MASS; BODY WEIGHT; CALORIC INTAKE; CARDIOVASCULAR RISK; CLINICAL TRIAL; COMPARATIVE STUDY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETES MELLITUS; DIASTOLIC BLOOD PRESSURE; DOUBLE BLIND PROCEDURE; DUAL ENERGY X RAY ABSORPTIOMETRY; FAT INTAKE; FAT SUBSTITUTE; FEEDING; FOOD INTAKE; GLUCOSE BLOOD LEVEL; HEALTH HAZARD; HEART DISEASE; HUMAN; INSULIN BLOOD LEVEL; LIPID BLOOD LEVEL; LIPOPROTEIN BLOOD LEVEL; LOW FAT DIET; MAJOR CLINICAL STUDY; MALE; METHODOLOGY; OBESITY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; RISK FACTOR; STANDARD; TIME; WEIGHT REDUCTION;

ADULT; APOLIPOPROTEINS; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, LDL; DIET, FAT-RESTRICTED; DIETARY FATS, UNSATURATED; DOUBLE-BLIND METHOD; FAT SUBSTITUTES; FATTY ACIDS; HUMANS; INSULIN; LEPTIN; MALE; OBESITY; RISK FACTORS; SUCROSE; TRIGLYCERIDES; WEIGHT LOSS;

EID: 0142057120     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802373     Document Type: Article

References (27)

1. Mensink RP, Katan MB. Effect of dietary fatty acids on serum lipids and lipoproteins. A meta-analysis of 27 trials. Arterioscler Thromb 1992; 12: 911-919.
2. Clarke R, Frost C, Collins R, Appleby P, Peto R. Dietary lipids and blood cholesterol: quantitative meta-analysis of metabolic ward studies. BMJ 1997; 314: 112-117.
3. Obarzanek E, Sacks FM, Vollmer WM, Bray GA, Miller ER III, Lin PH, Karanja NM, Most-Windhauser MM, Moore TJ, Swain JF, Bales CW, Proschan MA. Effects on blood lipids of a blood-pressure lowering diet: the Dietary Approaches to Stop Hypertension (DASH) Trial. Am J Clin Nutr 2001; 74: 80-89.
4. Willett WC. Is dietary fat a major determinant of body fat? Am J Clin Nutr 1998; 67 (Suppl): 556S-562S.
5. Dattilo AM, Kris-Etherton PM. Effects of weight reduction on blood lipids and lipoproteins: a meta-analysis. Am J Clin Nutr 1992; 56: 320-329.
6. Fukagawa NK, Anderson JW, Hageman G, Young VR, Minaker KL. High-carbohydrate, high-fiber diets increase peripheral insulin sensitivity in healthy young and old adults. Am J Clin Nutr 1990; 52: 524-528.
7. Lovejoy JC, Windhauser MM, Rood JC, Tulley R, de la Bretonne JA. Effect of a controlled high-fat vs. low-fat diet on insulin sensitivity and leptin levels in African-American and Caucasian women. Metabolism 1998; 47: 1520-1524.
8. Mayer-Davis EJ, Monaco JH, Hoen HM, Carmichael S, Carmichael S, Vitolins MZ, Rewers MJ, Haffner SM, Ayad MF, Bergman RN, Karter AJ. Dietary fat and insulin sensitivity in a triethnic population: the role of obesity. The Insulin Resistance and Atherosclerosis Study (IRAS). Am J Clin Nutr 1997; 65: 79-87.
9. Sjostrom CD, Lissner L, Sjostrom L. Relationships between changes in body composition and changes in cardiovascular risk factors: the SOS Intervention Study. Obes Res 1997; 5: 519-530.
10. Watts NB, Spanheimer RG, DiGirolamo M, Gebhart SSP, Musey VC, Siddiq YK, Phillips LS. Prediction of glucose response to weight loss in patients with non-insulin-dependent diabetes mellitus. Arch Intern Med 1990; 150: 803-806.
11. Sjostrom CD, Lissner L, Wedel H, Sjostrom L. Reduction in incidence of diabetes, hypertension and lipid disturbances after intentional weight loss induced by bariatric surgery: the SOS Intervention Study. Obes Res 1999; 7: 477-484.
12. Bray GA, Lovejoy JC, Most-Windhauser M, Smith SR, Volaufova J, Denkins Y, de Jonge E, Rood J, Lefevre M, Eldridge AL, Peters JC. A nine-month randomized clinical trial comparing a fat-substituted and fat-reduced diet in healthy obese men: the Ole' study. Am J Clin Nutr 2002; 76: 928-934.
13. Roy HJ, Most MM, Sparti A, Lovejoy JC, Volaufova J, Peters JC, Bray GA. Effect on body weight of replacing dietary fat with Olestra for two or ten weeks in healthy men and women. J Am Coll Nutr 2002; 21: 259-267.
14. Astrup A, Ryan L, Grunwald GK, Storgaard M, Saris W, Melanson E, Hill JO. The role of dietary fat in body fatness: evidence from a preliminary meta-analysis of ad libitum low-fat dietary intervention studies. Br J Nutr 2000; 83 (Suppl 1): S25-S32.
15. Bray GA, Popkin BM. Dietary fat intake does affect obesity. Am J Clin Nutr 1998; 68: 1157-1173.
16. Lissner L, Heitmann BL. Dietary fat and obesity: evidence from epidemiology. Eur J Clin Nutr 1995; 49: 79-90.
17. Yu-Poth S, Zhao G, Etherton T, Naglak M, Jonnalagadda S, Kris-Etherton PM. Effects of the National Cholesterol Education Program's Step I and Step II dietary intervention programs on cardiovascular disease risk factors: a meta-analysis. Am J Clin Nutr 1999; 69: 632-646.
18. Jandacek RJ, Ramirez MM, Crouse III JR. Effects of partial replacement of dietary fat by olestra on dietary cholesterol absorption in man. Metabolism 1990; 39: 848-852.
19. Mellies MJ, Jandacek RJ, Taulbee JD, Tewksbury MB, Lamkin G, Baehler L, King P, Boggs D, Goldman S, Gouge A, Tsang R, Glueck CJ. A double-blind, placebo-controlled study of sucrose polyester in hypercholesterolemic outpatients. Am J Clin Nutr 1983; 37: 339-346.
20. Garg A, Bonanome A, Grundy SM, Zhang Z-J, Unger RH. Comparison of a high-carbohydrate diet with a high-monounsaturated fat diet in patients with non-insulin-dependent diabetes mellitus. N Engl J Med 1988; 319: 829-934.
21. Jenkins DJ, Wolever TM, Rao AV, Hegele RA, Mitchell SJ, Ransom TP, Boctor DL, Spadafora PJ, Jenkins AL, Mehling C. Effect on blood lipids of very high intakes of fiber in diets low in saturated fat and cholesterol. N Engl J Med 1993; 329: 21-26.
22. Tillotson JL, Grandits GA, Bartsch GE, Stamler J. Relation of dietary carbohydrates to blood lipids in the special intervention and usual care groups in the Multiple Risk Factor Intervention Trial. Am J Clin Nutr 1997; 65(Suppl): 327S-337S.
23. Golay A, Felber JP, Dusmet M, Gomez F, Curchod B, Jequier E. Effect of weight loss on glucose disposal in obese and nonobese diabetic patients. Int J Obes Retat Metab Disord 1985; 9: 181-190.
24. Lovejoy J, DiGirolamo M. Progressive metabolic alterations in obesity prior to the onset of glucose intolerance. In: Sakamoto N, Angel A, Hotto N (eds), New directions in research and clinical works for obesity and diabetes mellitus, International Congress Series 963, Excerpta Medica. New York; 1991. pp. 171-174.
25. Marckmann P, Raben A, Astrup A. Ad libitum intake of low-fat diets rich in either starchy foods or sucrose: effects on blood lipids, factor VII coagulant activity, and fibrinogen. Metabolism 2000; 49: 731-735.
26. Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O'Rahilly S. Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 1997; 387: 903-908.
27. Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O'Rahilly S. Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 1999; 341: 879-884.